5-(3-Methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one

Catalog No. :
ACQXPB825
CAS No. :
219846-31-8
Molecular Formula :
C18H14N4O3
Molecular Weight :
334.33

IUPAC Name:5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one

5-(3-Methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$406.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(3-Methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one
IUPAC Name5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one
Molecular FormulaC18H14N4O3
Molecular Weight334.33
SMILESO=C1C(C2=NOC(C)=N2)=CC3=C(C4=CC(OC)=CC=C4)N=CC=C3N1
InChI KeyJQOFKKWHXGQABB-UHFFFAOYSA-N
SynonymMS-25042 | SX-3933 | Q7280124 | Resequinil [INN] | 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | AC 3933 | AKOS040742532 | AVE-3933 | JQOFKKWHXGQABB-UHFFFAOYSA-N | HY-106025 | DTXSID60944577 | Radequinil [INN]
CAS No.219846-31-8
PubChem CID135418404

Synthetic Route by SureRoute

1. ACQXPB825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACQXPB825 route product structure diagram
    ACQXPB825219846-31-8
Inquiry

2. ACQXPB825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLZOH286 route compound structure diagram
    ACLZOH28610365-98-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXPB825 route product structure diagram
    ACQXPB825219846-31-8
Inquiry

Comments (0)